Felipe Ades
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial.
Journal: Future oncology (London, England)
Published: October 08, 2025
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8.
Journal: Breast (Edinburgh, Scotland)
Published: June 07, 2023
Neoadjuvant treatment and survival outcomes by pathologic complete response in HER2-negative early breast cancers.
Journal: Future oncology (London, England)
Published: March 28, 2023
OncoAlert Round Table Discussions: The Global COVID-19 Experience.
Journal: JCO global oncology
Published: April 06, 2021
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.
Journal: Oncology and therapy
Published: July 13, 2020
VUS-type alteration in POLD1 and microsatellite instability in a metastatic luminal B breast cancer patient.
Journal: Ecancermedicalscience
Published: August 26, 2019
Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
Journal: PloS one
Published: October 01, 2017
The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches.
Journal: Ecancermedicalscience
Published: March 20, 2017
Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.
Journal: PloS one
Published: September 06, 2016
Phosphoethanolamine and the danger of unproven drugs.
Journal: Ecancermedicalscience
Published: July 15, 2016
Last Updated: 09/26/2026